PubRank

Ken Stein

Author PubWeight™ 42.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A multidimensional conceptual framework for analysing public involvement in health services research. Health Expect 2008 2.93
2 Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005 2.59
3 Hyperacute stroke care and NHS England's business plan. BMJ 2014 1.57
4 Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer. BJU Int 2011 1.51
5 Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia. Value Health 2011 1.48
6 The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective. Nephrol Dial Transplant 2007 1.47
7 Public health implications of establishing a national programme to screen young athletes in the UK. Br J Sports Med 2009 1.38
8 Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study. BMJ 2013 1.22
9 The experience of heavy menstrual bleeding: a systematic review and meta-ethnography of qualitative studies. J Adv Nurs 2008 1.21
10 Temozolomide for high grade glioma. Cochrane Database Syst Rev 2013 1.15
11 Temozolomide for high grade glioma. Cochrane Database Syst Rev 2008 1.11
12 Endoscopic sinus surgery for the excision of nasal polyps: A systematic review of safety and effectiveness. Am J Rhinol 2006 1.11
13 Factors influencing the implementation of fall-prevention programmes: a systematic review and synthesis of qualitative studies. Implement Sci 2012 1.06
14 Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review. BMC Fam Pract 2006 1.05
15 Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy? Diabetes Care 2012 1.03
16 Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev 2011 1.02
17 Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays. Stroke 2012 1.01
18 Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma. Value Health 2009 0.92
19 Telephone consultations in place of face to face out-patient consultations for patients discharged from hospital following surgery: a systematic review. BMC Health Serv Res 2013 0.92
20 Patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review of patient reported outcomes and patient and clinician satisfaction. BMC Health Serv Res 2013 0.92
21 The clinical effectiveness of patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review. PLoS One 2013 0.90
22 Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis. Pharmacoeconomics 2008 0.90
23 Effectiveness of mealtime interventions on nutritional outcomes for the elderly living in residential care: a systematic review and meta-analysis. Ageing Res Rev 2013 0.89
24 Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia. Pharmacoeconomics 2005 0.89
25 Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis? Stroke 2012 0.89
26 Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment. Pharmacoeconomics 2013 0.88
27 Chemotherapeutic wafers for High Grade Glioma. Cochrane Database Syst Rev 2008 0.88
28 Implementing the evidence for preventing falls among community-dwelling older people: a systematic review. J Safety Res 2011 0.87
29 A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG 2004 0.87
30 Multiple component interventions for preventing falls and fall-related injuries among older people: systematic review and meta-analysis. BMC Geriatr 2014 0.87
31 Establishing local priorities for a health research agenda. Health Expect 2012 0.85
32 Interventions to reduce acute paediatric hospital admissions: a systematic review. Arch Dis Child 2012 0.84
33 Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma. Value Health 2009 0.84
34 Is combined resynchronisation and implantable defibrillator therapy a cost-effective option for left ventricular dysfunction? Int J Cardiol 2008 0.83
35 Case finding for hepatitis C in primary care: a cost utility analysis. Fam Pract 2006 0.83
36 Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukemia. Int J Technol Assess Health Care 2012 0.79
37 Do metronomes improve the quality of life in people with Parkinson's disease? A pragmatic, single-blind, randomized cross-over trial. Clin Rehabil 2010 0.78
38 Involving patients in drug licensing decisions. BMJ 2013 0.77
39 Predictive value of asthma medication to identify asthma sufferers. Br J Gen Pract 2002 0.75
40 Mind sharpeners for scientists: the EQUATOR Network. Int J Technol Assess Health Care 2011 0.75
41 A rapid needs assessment of the provision of Health Technology Assessment in the south-west peninsula. J Public Health (Oxf) 2007 0.75
42 NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. Lancet Oncol 2011 0.75
43 Using information graphics in health technology assessment: toward a structured approach. Int J Technol Assess Health Care 2009 0.75
44 Adult attention deficit hyperactivity disorder (ADHD): public health implications. Perspect Public Health 2012 0.75
45 Cost effectiveness of oromucosal cannabis-based medicine (Sativex®) for spasticity in multiple sclerosis. Pharmacoeconomics 2012 0.75
46 Microwave and thermal balloon ablation for heavy menstrual bleeding: a systematic review. BJOG 2005 0.75
47 Erratum to: cost effectiveness of Oromucosal cannabis-based medicine (Sativex(®)) for spasticity in multiple sclerosis. Pharmacoeconomics 2015 0.75